Celgene

Four NCI Cancer Centers form Consortium, collaborate with Celgene

Tuesday, June 28, 2016

The Abramson Cancer Center at the University of Pennsylvania, The Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai announced the establishment of a research consortium focused on accelerating the discovery and development of novel cancer therapeutics and diagnostics for the benefit of patients.

[Read More]

Cancer Centers, biopharmaceuticals collaborate on precision medicines

Wednesday, April 20, 2016

M2Gen, a healthcare informatics solutions company, has announced a collaboration with pharmaceutical companies and the Oncology Research Information Exchange Network (ORIEN), an alliance of cancer centers throughout the U.S. M2Gen also announced that Celgene will be the industry’s founding member of a network of participants joining in this new initiative. The launch of the ORIEN Avatar Research Program brings together the pre-eminent players in healthcare R&D pharmaceutical companies and academic cancer centers to find new treatments for millions of Americans battling advanced-stage cancers.

[Read More]

Celgene announces exec changes, including Hugan and executive chairman

Tuesday, January 12, 2016

Celgene has announced organizational changes that will position the company for continued long-term growth, effective March 1. Bob Hugin will serve as executive chairman. Hugin will continue to lead the board of directors and manage the strategic direction of the company. Mark Alles will be promoted to chief executive officer. Jacqualyn Fouse, Ph.D., will be promoted to president and chief operating officer. Scott Smith, president of immunology and inflammation, will assume an expanded leadership role.

[Read More]

Human Longevity acquires Cypher Genomics

Monday, November 30, 2015

San Diego’s Human Longevity Inc. (HLI), a genomics-based, technology-driven company, has acquired Cypher Genomics, a genome informatics company offering human genomic interpretation software solutions. The company has 14 employees who will join HLI, including Cypher CEO and co-founder Ashley Van Zeeland, Ph.D., who now is the head of HLI’s pediatric business. Financial details of the deal were not disclosed.

[Read More]